IP Library Granted Patent US 7,390,636
Granted Patent B2
US 7,390,636 · App. 11/102,475 · Granted Jun 24, 2008

Method for construction and use of

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,390,636
App. No.
11/102,475
Granted
Jun 24, 2008
Kind
B2
Abstract

Methods and compositions are provided relating to production of recombinant protein in yeast. A modified P LAC4 is described where one or more mutations may be introduced into the Pribnow box-like sequences in the promoter. The modified promoter when placed upstream of a target gene in a vector causes a significant reduction of target gene expression in transformed bacteria but produces efficient expression of the target gene in yeast.

Claims (19)

1. A method of producing a recombinant protein in yeast cells, comprising:

(a) obtaining a vector into which a gene encoding the target protein has been inserted, the vector further comprising: a modified P LAC4 having a mutation in one or more Pribnow box-like sequences wherein the modification results in a significant reduction in gene expression when the vector is cloned in bacteria;

(b) transforming yeast cells with the vector; and

(c) producing an effective amount of the recombinant protein in the yeast cells.

2. A method according to claim 1 , wherein the one or more Pribnow box-like sequences are PBI, PBII and PBIII.

3. A method according to claim 1 , wherein the mutation is in two or more Pribnow box-like sequences.

4. A method according to claim 1 , wherein the modified P LAC4 has one or more mutations in a first region of the promoter corresponding to nucleotides −198 to −212.

5. A method according to claim 1 , wherein the modified P LAC4 has one or more mutations in a second region of the promoter corresponding to nucleotides −133 to −146.

6. A method according to claim 1 , wherein nucleotides −1 to −283 in the modified P LAC4 are substituted by nucleotides −1 to −283 of a phosphoglycerate kinase promoter from S. cerevisiae.

7. A method according to claim 1 , wherein the vector in the transformed yeast cells is an episomal plasmid.

8. A method according to claim 1 , wherein the vector in the transformed yeast cells is an integrative plasmid.

9. A vector, comprising: a modified P LAC4 promoter having a mutation in one or more Pribnow box-like sequences operatively linked to a gene encoding a target protein.

10. A vector according to claim 9 , wherein the one or more Pribnow box-like sequences are PBI, PBII and PBIII.

11. A vector according to claim 9 , wherein the mutation is in two or more Pribnow box-like sequences.

12. A vector according to claim 9 , wherein the modified P LAC4 has one or more mutations in a first region of the promoter corresponding to nucleotides −198 to −212.

13. A vector according to claim 9 , wherein the modified P LAC4 has one or more mutations in a second region of the promoter corresponding to nucleotides −133 to −146.

14. A vector according to claim 9 , wherein nucleotides −1 to −283 in the modified P LAC4 are substituted by nucleotides −1 to −283 of a phosphoglycerate kinase promoter from S. cerevisiae.

15. A host yeast cell comprising a vector of claim 9 .

16. A kit, comprising: a vector according to claim 9 ; and optionally, competent yeast cells and instructions for use.

Assignments (2)
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Sep 27, 2023
From: NEW ENGLAND BIOLABS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065044/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2005
From: TARON, CHRISTOPHER; COLUSSI, PAUL
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 016693/0729 →